Stock analysis and insights from Openbook's Individual Stock Analysis category.
This Experian stock analysis sets out FY26 revenue of US$8,425m, a 28.6% benchmark EBIT margin and the regional mix behind EXPN shares, plus the dividend, buybacks and leverage picture.
An Aviva share price analysis of how the FTSE 100 insurer earns across general insurance, protection and wealth, and what the H1 2026 numbers show.
A Linde stock analysis covering how LIN earns money from on-site, merchant and packaged gases, plus margins, backlog, dividend and the risks to watch.
GE Vernova (GEV) stock analysis: record orders, a USD 176 billion backlog and what the Power, Electrification and Wind segments show in 2026.
A Vodafone stock analysis of the FY26 results and Q1 FY27 update, covering German broadband, VodafoneThree and African mobile money. Looks at revenue, margins, net debt and the dividend.
An Imperial Brands stock analysis of the FY2025 and H1 FY2026 figures. It covers the five priority markets, NGP growth, cash conversion and the dividend.
This UnitedHealth stock analysis breaks down the Q2 2026 numbers, the medical care ratio, and how the Optum and UnitedHealthcare margins moved.
Wells Fargo stock analysis: how its four segments earn revenue and what the latest reported quarter showed. Plus what lifting the asset cap changed.
A Tesco stock analysis grounded in the FY2025/26 preliminary results. It covers segment margins, UK market share, free cash flow and the reported Central Europe sale.
Prudential stock analysis for London listed insurer PRU: how it earns new business profit across Asia and Africa, and what the H1 2026 figures showed.
A Morgan Stanley stock analysis of the latest reported numbers: record Q2 2026 revenues, wealth flows, capital ratios and what the multiples measure.
RTX stock analysis of the aerospace and defense group behind Collins Aerospace, Pratt and Whitney and Raytheon. We look at the Q2 2026 results, the $289 billion backlog, the dividend and the geared turbofan engine program.
SSE stock analysis for the FY2026 results, the RIIO-T3 price control and a 33 billion pound capital plan. What the numbers show and what would change them.
This Coca-Cola Europacific Partners (CCEP) stock analysis looks at the bottler behind the brand: H1 2026 revenue, margins, net debt and the dividend.
A Philip Morris stock analysis of the PM smoke-free shift. We look at Q2 2026 revenue, IQOS and ZYN volumes, margins, leverage and the newly raised dividend.
Goldman Sachs stock analysis: how GS earns money across advisory, trading and asset management, what Q2 2026 reported, and the capital and cycle risks.
This Haleon stock analysis covers the consumer health group behind Sensodyne and Panadol: FY2025 and H1 2026 figures, margins, dividend and risks.
This 3i Group stock analysis examines how Action came to be three quarters of the portfolio, and what the latest NAV, dividend and gearing figures show.
A Diageo stock analysis built on the FY2026 accounts: net sales, the North America slowdown, the rebased dividend, and reading pence quotes against dollar earnings.
Antofagasta stock analysis covers a copper producer with four Chilean mines. H1 2026 brought record margins on higher prices and 9 per cent lower output.
A Merck stock analysis of where MRK earns its revenue across oncology, vaccines and animal health, and what the 2028 Keytruda patent expiry changes.
A Cisco stock analysis built on the FY2026 numbers. Revenue reached $63.3 billion, up 12%, while product gross margin fell. Here is what drives the business and what to watch next.
A Standard Chartered stock analysis of the FTSE 100 bank: H1 2026 income, returns and capital, and the Asian trade and wealth flows behind the numbers.
A Lam Research stock analysis of the etch and deposition maker: fiscal 2026 results, its installed-base service business, and the risks to watch.
A RELX stock analysis of how the FTSE 100 information group earns its revenue, and what the latest reported growth, margin and debt figures show.
A London Stock Exchange Group (LSEG) stock analysis of how its income splits. We look at H1 2026 margins, subscription growth and capital returns.
A Reckitt Benckiser stock analysis of the H1 2026 numbers: revenue, margins, dividend, the Essential Home disposal and the unresolved Mead Johnson exit.
A Netflix stock analysis of the streaming business: Q2 2026 revenue, margins, the advertising build-out, free cash flow and what to watch from here.
A Coca-Cola stock analysis of the concentrate model, second quarter 2026 results, unit case volume, the dividend record and the risks now in play.
A Palantir stock analysis grounded in the Q2 2026 results: 93 percent revenue growth, the US government and commercial split, margins, cash and dilution.
A Moderna stock analysis after the 177 percent move: what the INTerpath-001 melanoma readout disclosed, Q2 2026 revenue and losses, and the cash runway.
This Chevron stock analysis looks at how CVX earns money across upstream and downstream, its latest reported figures, dividend cover and the risks to watch.
A GE Aerospace stock analysis covering how the engine maker earns from spare parts and overhauls, its Q2 2026 results and raised guidance, and the backlog, margin mix and risks worth tracking.
This AbbVie stock analysis breaks down Q2 2026 results, the Skyrizi and Rinvoq franchises that replaced Humira, margins, the dividend and key risks.
A Glencore share price analysis of the miner and its trading desk: what the H1 2026 numbers showed, how cash gets returned, and the risks to watch.
A BAE Systems stock analysis of the FTSE 100 defence group: what its five segments earn, what the H1 2026 numbers show, and which risks matter most.
A Compass Group stock analysis of the FTSE 100 caterer: how contract catering earns its margin, what FY2025 and H1 2026 show, and what to watch.
This Bank of America stock analysis breaks down the bank's four segments, its Q2 2026 results, and the deposit, fee and credit drivers behind them.
A Caterpillar stock analysis covering the three machine segments, Cat Financial, the record 72 billion dollar backlog and the tariff costs behind the reported numbers.
A Home Depot stock analysis of the business behind the orange aprons: 2,359 stores, the SRS and GMS distribution deals, and what Q1 fiscal 2026 showed.
Costco stock analysis: how membership fees, an 11% gross margin and steady warehouse openings shape what COST actually reports each quarter.
An Oracle stock analysis grounded in fiscal 2026 results: $67.4bn revenue, a $638bn contracted backlog and $55.7bn of capex. What the numbers show and what to watch.
A Procter and Gamble (PG) stock analysis grounded in the fiscal 2026 results: organic sales, margins, the dividend record and the fiscal 2027 cost headwinds worth watching.
A Unilever stock analysis of the H1 2026 results: volume-led growth, margins, cash flow and the dividend. We look at what drives the numbers and what to watch next.
A British American Tobacco stock analysis: how BATS earns from cigarettes and smokeless nicotine, and what its dividend, debt and risks show.
A National Grid share price analysis of the FY2026 results: record 11.6bn capital investment, 78.0p underlying EPS and the new RIIO-T3 price control.
This eli lilly stock analysis examines Q1 2026 earnings, the revenue contributions from Mounjaro, Zepbound and Foundayo, the growing oncology pipeline, dividend profile, balance sheet and current LLY valuation multiples. Understand the key drivers and risks shaping Eli Lilly's fundamental picture in 2026.
An Exxon Mobil (XOM) stock analysis of the Q2 2026 numbers, the Guyana and Permian growth engines, capital returns and the risks worth watching.
An AMD stock analysis of the second quarter 2026 numbers: data center growth, margins, cash, the Helios accelerator ramp and the risks to track.
A Mastercard (MA) stock analysis grounded in reported figures: how the network earns its fees, what the latest quarter showed, and what to watch next.
This Walmart stock analysis examines how WMT's grocery market dominance is fuelling a fast-growing retail media and membership business, with data from the Q1 FY27 earnings release (reported 21 May 2026) and full-year FY26 results.
This GSK stock analysis examines GlaxoSmithKline's Q2 2026 results, vaccines pipeline momentum, dividend cover and balance sheet position following the Nuvalent acquisition. Explore the key financial metrics and risks shaping the investment case in 2026.
This Broadcom stock analysis examines AVGO's Q2 FY2026 earnings, record AI chip revenue growth, balance sheet structure, dividend cover, and valuation multiples — so you can assess the fundamentals for yourself.
This SpaceX (SPCX) stock analysis examines the company's first public financials, covering 2025 revenue of $18.67 billion, segment results across Starlink, space and AI, and the valuation multiples applied after the record-breaking June 2026 IPO.
This Shell plc share price analysis examines the company's Q1 2026 earnings beat, dividend cover, balance sheet trends and the strategic implications of the ARC Resources acquisition. Explore the key financial signals and risks shaping the investment case for SHEL in 2026.
This rio tinto stock analysis examines the key financial metrics from Rio Tinto plc's (RIO) 2025 full year results, including iron ore margins, dividend cover, balance sheet leverage and valuation multiples. Understand the drivers, the risks and what to watch next.

This analysis covers Apple, Rolls-Royce, Meta Platforms, and Riot Platforms — breaking down the key financial drivers, valuation signals, and risks shaping each stock in 2026.